Sean X. Du
Keine laufenden Positionen mehr
Profil
Dr. Sean X.
Du is Chief Operating Officer at Altravax, Inc.
Dr. Du was previously employed as Executive Director by Simcere Pharmaceutical Group and a Principal by Maxygen, Inc.
He received his undergraduate degree from Shandong University, a graduate degree from the Chinese Academy of Sciences, and a doctorate degree from the University of Delaware.
Ehemalige bekannte Positionen von Sean X. Du
| Unternehmen | Position | Ende |
|---|---|---|
| SIMCERE PHARMACEUTICAL GROUP LIMITED | Direktor/Vorstandsmitglied | 01.01.2013 |
Maxygen, Inc.
 Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | Corporate Officer/Principal | 01.01.2009 |
Altravax, Inc.
 Altravax, Inc. Pharmaceuticals: MajorHealth Technology Altravax, Inc. discovers and develops new vaccines to fight infectious diseases. The firm’s proprietary technologies offer unique opportunities to create novel vaccine or improve currently available alternatives to fill unmet medical needs. It provides contract services. It has a robust pipeline of candidates at various stages of development. The company was founded by Sean X. Du and Robert Whalen in 2009 and is headquartered in Sunnyvale, CA. | Gründer | - |
Ausbildung von Sean X. Du
| Shandong University | Undergraduate Degree |
| Chinese Academy of Sciences | Graduate Degree |
| University of Delaware | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SIMCERE PHARMACEUTICAL GROUP LIMITED | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Altravax, Inc.
Altravax, Inc. Pharmaceuticals: MajorHealth Technology Altravax, Inc. discovers and develops new vaccines to fight infectious diseases. The firm’s proprietary technologies offer unique opportunities to create novel vaccine or improve currently available alternatives to fill unmet medical needs. It provides contract services. It has a robust pipeline of candidates at various stages of development. The company was founded by Sean X. Du and Robert Whalen in 2009 and is headquartered in Sunnyvale, CA. | Health Technology |
Maxygen, Inc.
Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | Commercial Services |
